Analyst consensus rating
Bionano Genomics Analyst Rating: none
Direct answer
Bionano Genomics's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.00.
Forecast evidence checked September 5, 2026.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.20
- Average price target
- $5.00
- High price target
- $6.00
- Low price target
- $4.00
- Low target gap
- +233.3%
- Target upside
- +316.7%
- High target gap
- +400%
- Target range width
- 166.7%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bionano Genomics?
Bionano Genomics has a verified none consensus. The same dataset has an average price target of $5.00.
How far are Bionano Genomics's low and high targets from the recorded price?
The low target implies +233.3%, while the high target implies +400%.
How many analysts are included in Bionano Genomics's consensus?
The verified consensus includes 2 analysts.
How is Bionano Genomics's target upside or downside calculated?
The average target of $5.00 is divided by the recorded price of $1.20, then one is subtracted to produce +316.7%. This does not guarantee a future return.
When was Bionano Genomics's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.